AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO ® Impulse System for ...

San Leandro, Calif. December 20, 2007 - PhaseSpace, the price and performance leader in optical motion capture systems and technology, announced today that Cilantro Animation Studios has deployed the ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering Cardiac Contractility Modulation (also known as CCM™ therapy), announced that ...

designed to reduce severe heart attack impairment when used as an adjunct therapy with angioplasty in acute STEMI and NSTEMI patients. Company appoints Cajetan von König as Director of Sales and ...

San Leandro, Calif. February 13, 2008 - PhaseSpace, the price and performance leader in optical motion capture, announced today a new desktop motion capture product - the IMPACT, to be shown for the ...

PARIS – Miracor Medical SA secured a $28 million series E funding round for its Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) impulse system, intended for treating patients ...

VIENNA, Austria - Miracor Medical Systems announced today that results from the ‘Prepare RAMSES’ clinical trial will be disclosed at ‘TCT 2014’ in Washington, D.C. The Prepare RAMSES trial was a ...

IN a recent communication 1, Hertz has postulated an impulse transmission system in which “potassium ions, which have been lost from one nerve cell during its activity, are transported through ...